ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
105.050,41
0,31%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX

  6. Aeterna Zentaris Inc (AEZS) Börsenkurse

Aeterna Zentaris Inc

Aeterna Zentaris Inc (AEZS)

TSX
8,29
0,00
(0,00%)
Geschlossen 26 Januar 10:12PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
8,29
Gebot
6,01
Fragen
9,20
Volumen
-
0,00 Tagesbereich 0,00
5,40 52-Wochen-Bereich 15,13
Marktkapitalisierung
40,256M
Handelsende
8,29
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
4.856.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,09
Gewinn pro Aktie (EPS)
-3,41
Erlöse
4,5M
Nettogewinn
-16,55M

Über Aeterna Zentaris Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.zentaris.com/
Hauptsitz
Toronto, Ontario, Can
Gegründet
-
Aeterna Zentaris Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker AEZS. The last closing price for Aeterna Zentaris was $8,29. Over the last year, Aeterna Zentaris shares have traded in a share price range of $ 5,40 to $ 15,13.

Aeterna Zentaris currently has 4.856.000 shares in issue. The market capitalisation of Aeterna Zentaris is $40,26 million. Aeterna Zentaris has a price to earnings ratio (PE ratio) of -1.09.

AEZS Neueste Nachrichten

Weitere Nachrichten

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) ("COSCIENS" or the "Company"), a specialty...

07 August 2024
GlobeNewswire Inc.

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and...

16 Juli 2024
GlobeNewswire Inc.

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or...

13 Juni 2024
GlobeNewswire Inc.

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF...

03 Juni 2024
GlobeNewswire Inc.

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two...

03 Juni 2024
GlobeNewswire Inc.

Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and...

30 Mai 2024
GlobeNewswire Inc.

Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces that it has finalized certain details regarding the...

17 Mai 2024
GlobeNewswire Inc.

Aeterna Zentaris Reports First Quarter 2024 Financial Results

Company ended the quarter with $29.5 million in cashDETECT-trial recruitment completed; Company continues to expect the completion of the trial in the second quarter and top-line data in the third...

15 Mai 2024
GlobeNewswire Inc.

Aeterna Zentaris Announces Effective Date of Share Consolidation

TORONTO, ON, May 01, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces that it has filed articles of amendment to effect the...

01 Mai 2024
GlobeNewswire Inc.

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

28 März 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1008.298.298.2900CS
4008.298.298.2900CS
12008.298.298.2900CS
260.7810.38615179767.518.567.06927.86144921CS
52-1.95-19.0429687510.2415.135.410599.93082113CS
1566.65405.4878048781.6429.640.8687583.31756135CS
2601.1716.43258426977.1229.640.86637365.48118985CS

AEZS - Frequently Asked Questions (FAQ)

What is the current Aeterna Zentaris share price?
The current share price of Aeterna Zentaris is $ 8,29
How many Aeterna Zentaris shares are in issue?
Aeterna Zentaris has 4.856.000 shares in issue
What is the market cap of Aeterna Zentaris?
The market capitalisation of Aeterna Zentaris is CAD 40,26M
What is the 1 year trading range for Aeterna Zentaris share price?
Aeterna Zentaris has traded in the range of $ 5,40 to $ 15,13 during the past year
What is the PE ratio of Aeterna Zentaris?
The price to earnings ratio of Aeterna Zentaris is -1,09
What is the cash to sales ratio of Aeterna Zentaris?
The cash to sales ratio of Aeterna Zentaris is 4,02
What is the reporting currency for Aeterna Zentaris?
Aeterna Zentaris reports financial results in USD
What is the latest annual turnover for Aeterna Zentaris?
The latest annual turnover of Aeterna Zentaris is USD 4,5M
What is the latest annual profit for Aeterna Zentaris?
The latest annual profit of Aeterna Zentaris is USD -16,55M
What is the registered address of Aeterna Zentaris?
The registered address for Aeterna Zentaris is AETERNA ZENTARIS INC, 222 BAY STREET, SUITE 3000, TORONTO, ONTARIO, M5K 1E7
What is the Aeterna Zentaris website address?
The website address for Aeterna Zentaris is www.zentaris.com/
Which industry sector does Aeterna Zentaris operate in?
Aeterna Zentaris operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DIAMStar Diamond Corporation
$ 0,04
(33,33%)
851,62k
RAY.BStingray Group Inc
$ 7,95
(20,64%)
3k
EDTSpectral Medical Inc
$ 0,59
(15,69%)
68,5k
FRXFennec Pharmaceuticals Inc
$ 9,00
(13,92%)
8,33k
YRBYorbeau Resources Inc
$ 0,045
(12,50%)
1,44M
GLOGlobal Atomic Corporation
$ 0,63
(-32,98%)
14,4M
APLIAppili Therapeutics Inc
$ 0,03
(-14,29%)
108k
KRNKarnalyte Resources Inc
$ 0,12
(-14,29%)
4,07k
XAMXanadu Mines Ltd
$ 0,045
(-10,00%)
12,02k
AVCNAvicanna Inc
$ 0,28
(-9,68%)
303,69k
GLOGlobal Atomic Corporation
$ 0,63
(-32,98%)
14,4M
BMOBank of Montreal
$ 144,87
(0,61%)
7,29M
ENBEnbridge Inc
$ 64,61
(0,19%)
7,26M
TDToronto Dominion Bank
$ 82,18
(-0,06%)
5,9M
BCEBCE Inc
$ 33,77
(1,17%)
5,26M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSX
AEZS
Aeterna Zentaris
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten